4.6 Article

Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR)

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Do the Benefits of Participation in a Hypertension Self-Management Trial Persist After Patients Resume Usual Care?

Matthew L. Maciejewski et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2014)

Article Medicine, General & Internal

Hypertension management in England: a serial cross-sectional study from 1994 to 2011

Emanuela Falaschetti et al.

LANCET (2014)

Article Cardiac & Cardiovascular Systems

Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis

Billingsley Kaambwa et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)

Article Transplantation

Estimating the financial cost of chronic kidney disease to the NHS in England

Marion Kerr et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

Review Medicine, General & Internal

Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

Ashish Upadhyay et al.

ANNALS OF INTERNAL MEDICINE (2011)

Article Cardiac & Cardiovascular Systems

Beyond the randomized clinical trial - The role of effectiveness studies in evaluating cardiovascular therapies

Brahmajee K. Nallamothu et al.

CIRCULATION (2008)

Article Economics

The economic burden of stroke in the United Kingdom

P Youman et al.

PHARMACOECONOMICS (2003)